Eisbach Bio is a series a startup based in Germany. 3 investors tracked.
Based in Germany, Eisbach Bio is a startup founded in 2020. Its most recent tracked round is Series A. Brouky records 3 investors associated with the company.
Eisbach Bio is a biotechnology company leveraging its proprietary compound collections to develop novel therapeutics.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.